Novartis/Ophthotech eye combo fails in phase 3
Lucentis and pegpleranib combination misses goal in wet AMD.
X
Novartis/Ophthotech eye combo fails in phase 3
https://pharmaphorum.com/news/novartisophthotech-eye-combo-fails-phase-3/
Lucentis and pegpleranib combination misses goal in wet AMD.